US2019112581A1PendingUtilityA1
Host Cell Modification with Artificial Endosymbionts
Est. expirySep 3, 2033(~7.1 yrs left)· nominal 20-yr term from priority
C07K 14/195C12N 2510/00C12N 5/16C12N 15/87C07K 2319/034C12N 1/20C07K 14/435
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed generally to host cells with artificial endosymbionts, wherein the artificial endosymbiont and the host cell communicate with each other to alter a phenotype of the host cell. In some embodiments, the communication comprises the secretion of a polypeptide from the artificial endosymbiont into the host cell. The secreted polypeptide can be a selectable marker, a reporter protein, a transcription factor, a signal pathway protein, a receptor, a growth factor, a cytokine, an effector molecule or other factors that can produce a phenotype in the host cell.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . (canceled)
17 . An isolated mammalian cell comprising a magnetotactic bacterium, wherein the magnetotactic bacterium provides a protein to the host cell and thereby provides a phenotype to the mammalian cell, and wherein the mammalian cell is a hematopoietic cell.
18 . The mammalian cell of claim 17 , wherein the hematopoietic cell is a T-cell.
19 . The mammalian cell of claim 17 , wherein the hematopoietic cell is a B-cell.
20 . The mammalian cell of claim 17 , wherein the hematopoietic cell is a human cell.
21 . The mammalian cell of claim 17 , wherein the hematopoietic cell is a rodent cell.
22 . The mammalian cell of claim 17 , wherein the protein is a reporter.
23 . The mammalian cell of claim 22 , wherein the reporter is a PET reporter or an optical reporter.
24 . The mammalian cell of claim 18 , wherein the T-cell is a human T-cell.
25 . The mammalian cell of claim 18 , wherein the hematopoietic cell is in a mammal.
26 . The mammalian cell of claim 18 , wherein the hematopoietic cell is in a rodent.Join the waitlist — get patent alerts
Track US2019112581A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.